Michael S. Hearne, Officer, Chief Financial Officer, Chief Operating Officer, Chief Executive Officer at Odonate Therapeutics, Inc. (ODT), bought 98,095 shares at $26.89 ($2.6M) on 2019-06-18, disclosed to the SEC on 2019-06-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.95 | 18,608 | $464K | 18.1% |
| 2 | $24.95 | 18,608 | $464K | 18.1% |
| 3 | $26.20 | 1,905 | $50K | 1.9% |
| 4 | $26.95 | 8,137 | $219K | 8.5% |
| 5 | $26.95 | 8,137 | $219K | 8.5% |
| 6 | $26.89 | 21,350 |
| $574K |
| 22.4% |
| 7 | $26.89 | 21,350 | $574K | 22.4% |
| Total | $26.15 avg | 98,095 | $2.6M | 100% |
| Filing → |